SEC Form 4 · accession 0001179110-15-007642
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael G Howley
Officer — VP, Global Sales & Marketing
Period of report
May 8, 2015
Accepted (ET)
May 12, 2015 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par value | May 8, 2015 | M | 14,301 | $5.23 | A | 97,601 | D | |
| Common Stock, $.01 par valueF4,F5 | May 8, 2015 | S | 2,701 | $64.1597 | D | 94,900 | D | |
| Common Stock, $.01 par valueF4,F6 | May 8, 2015 | S | 3,032 | $65.1294 | D | 91,868 | D | |
| Common Stock, $.01 par valueF4,F7 | May 8, 2015 | S | 1,593 | $66.3304 | D | 90,275 | D | |
| Common Stock, $.01 par valueF4,F8 | May 8, 2015 | S | 4,068 | $67.3335 | D | 86,207 | D | |
| Common Stock, $.01 par valueF4,F9 | May 8, 2015 | S | 2,303 | $67.8776 | D | 83,904 | D | |
| Common Stock, $.01 par valueF4,F10 | May 8, 2015 | S | 544 | $69.0306 | D | 83,360 | D | |
| Common Stock, $.01 par valueF4,F11 | May 8, 2015 | S | 60 | $69.81 | D | 83,300 | D | |
| Common Stock, $.01 par valueF4,F12,F19 | May 8, 2015 | S | 274 | $64.1598 | D | 83,026 | D | |
| Common Stock, $.01 par valueF4,F13,F19 | May 8, 2015 | S | 307 | $65.1294 | D | 82,719 | D | |
| Common Stock, $.01 par valueF4,F14,F19 | May 8, 2015 | S | 162 | $66.3304 | D | 82,557 | D | |
| Common Stock, $.01 par valueF4,F15,F19 | May 8, 2015 | S | 412 | $67.3336 | D | 82,145 | D | |
| Common Stock, $.01 par valueF4,F16,F20 | May 8, 2015 | S | 234 | $67.877 | D | 81,911 | D | |
| Common Stock, $.01 par valueF4,F17 | May 8, 2015 | S | 55 | $69.0306 | D | 81,856 | D | |
| Common Stock, $.01 par valueF4,F18 | May 8, 2015 | S | 6 | $69.81 | D | 81,850 | D | |
| Common Stock, $.01 par valueF4 | May 12, 2015 | S | 1,602 | $68.00 | D | 80,248 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $5.23 | May 8, 2015 | M | 14,301 | D | Mar 5, 2009 | Mar 5, 2019 | Common Stock | 14,301 | 0 | D |
| Stock Option (right to buy)F1,F2 | $10.03 | holding | — | — | — | Jun 3, 2011 | Jun 3, 2020 | Common Stock | 0 | 30,000 | D |
| Stock Option (Right to buy)F1,F2 | $22.44 | holding | — | — | — | May 22, 2013 | May 22, 2022 | Common Stock | 0 | 25,000 | D |
| Stock Option (Right to Buy)F1,F2 | $23.15 | holding | — | — | — | May 14, 2014 | May 14, 2023 | Common Stock | 0 | 25,000 | D |
| Stock Option (Right to Buy)F1,F3 | $21.55 | holding | — | — | — | May 14, 2015 | May 14, 2024 | Common Stock | 0 | 25,000 | D |
Explanation of responses
- F1Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
- F10This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $68.7000 and $69.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F11This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.7000 and $69.9600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F12This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $63.6200 and $64.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F13This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $64.6200 and $65.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F14This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $65.6750 and $66.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F15This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $66.7000 and $67.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F16This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $67.7000 and $68.6600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F17This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $68.7000 and $69.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F18This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.7000 and $69.9600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F19To remedy a broker error that occurred in connection with executing the transaction, in accordance with the broker's policy, the reporting person received from the broker an additional payment for the sale of the shares to make the average price per share $68.0000.
- F2These options become exerciseable in annual 25% increments, commencing on the date shown forth in Table II, Column 6.
- F20To remedy a broker error that occurred in connection with executing the transaction, in accordance with the broker's policy, the reporting person received from the broker an additional payment for the sale of the shares sold below $68.0000 per share to make the price per share of such shares $68.0000 per share.
- F3These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- F4Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- F5This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $63.6200 and $64.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F6This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $64.6200 and $65.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F7This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $65.6750 and $66.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F8This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $66.7000 and $67.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F9This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $67.7000 and $68.6600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.